Citation 131060

OKANO,M: FUKAMIYA,N: TAGAHARA,K: TOKUDA,H: IWASHIMA,A: NISHINO,H: LEE,KH:. (1995). INHIBITORY EFFECTS OF QUASSINOIDS ON EPSTEIN-BARR VIRUS ACTIVATION.. 94(2)

Citation Details

TitleINHIBITORY EFFECTS OF QUASSINOIDS ON EPSTEIN-BARR VIRUS ACTIVATION.
AuthorsOKANO,M: FUKAMIYA,N: TAGAHARA,K: TOKUDA,H: IWASHIMA,A: NISHINO,H: LEE,KH:
Year1995
Volume94
Issue2

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEIN D
ACTIVE
2
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
YADANZIOLIDE C
WEAK ACTIVITY
3
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEIN E
ACTIVE
4
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
YADANZIOSIDE F
ACTIVE
5
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
YADANZIOSIDE L
ACTIVE
6
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEOSIDE C
ACTIVE
7
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEOSIDE B
ACTIVE
8
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
YADANZIOSIDE C
ACTIVE
9
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
YADANZIOSIDE B
ACTIVE
10
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEOSIDE A
ACTIVE
11
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
YADANZIOSIDE E
ACTIVE
12
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
YADANZIOSIDE M
ACTIVE
13
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
YADANZIOSIDE A
ACTIVE
14
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
YADANZIOSIDE G
ACTIVE
15
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANTINOSIDE A
ACTIVE
16
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEIN B,ISO:
STRONG ACTIVITY
17
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANTARIN,DEHYDRO:
ACTIVE
18
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANTINOSIDE C
ACTIVE
19
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANOL A
STRONG ACTIVITY
20
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANTINOSIDE B
ACTIVE
21
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANOL C
STRONG ACTIVITY
22
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
YADANZIOSIDE N
ACTIVE
23
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANOL G
STRONG ACTIVITY
24
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANTINOL,DEHYDRO:
STRONG ACTIVITY
25
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANOL D
STRONG ACTIVITY
26
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANTIN,DEHYDRO:
STRONG ACTIVITY
27
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANOL B
STRONG ACTIVITY
28
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANTIN
STRONG ACTIVITY
29
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANOL F
ACTIVE
30
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANOL E
STRONG ACTIVITY
31
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRUCEANOL H
ACTIVE
32
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PICRASIN B
ACTIVE
33
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NIGAKILACTONE F
WEAK ACTIVITY
34
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NIGAKILACTONE H
ACTIVE
35
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NIGAKILACTONE L
ACTIVE
36
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PICRASIN A
WEAK ACTIVITY
37
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NIGAKILACTONE E
WEAK ACTIVITY
38
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
QUASSIN
WEAK ACTIVITY
39
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PICRASINOL D
WEAK ACTIVITY
40
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NIGAKIHEMIACETAL A
WEAK ACTIVITY
41
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PICRASIN E
WEAK ACTIVITY
42
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PICRASINOL C
WEAK ACTIVITY
43
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NIGAKIHEMIACETAL D
ACTIVE
44
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PICRASIN D
WEAK ACTIVITY
45
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
QUASSIN,NEO:
WEAK ACTIVITY
Show SPARQL Queries (1)